Lytix Biopharma AS
F:6BG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lytix Biopharma AS
F:6BG
|
NO |
|
Brisbane Broncos Ltd
ASX:BBL
|
AU |
|
Bluestone Resources Inc
XTSX:BSR
|
CA |
|
I
|
Isu Chemical Co Ltd
KRX:005950
|
KR |
|
Izertis SA
MAD:IZER
|
ES |
|
C
|
Compass Group PLC
OTC:CMPGF
|
UK |
|
A
|
Abacore Capital Holdings Inc
XPHS:ABA
|
PH |
|
Lumos Pharma Inc
NASDAQ:LUMO
|
US |
|
Methanol Chemicals Company SJSC
SAU:2001
|
SA |
|
Park Lawn Corp
TSX:PLC
|
CA |
Dividends
Dividend Yield
Lytix Biopharma AS
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Lytix Biopharma AS
Payout Ratio
Lytix Biopharma AS
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 6BG is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
6BG Price
Lytix Biopharma AS
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -11% |
| Market Capitalization | 799.8m EUR |
| Shares Outstanding | 608 658 |
| Percentage of Shares Shorted |
N/A
|
